Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-03

IMTX vs VOR: stock comparison and AI forecast

Immatics N.V. (IMTX) and Vor Biopharma Inc. (VOR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Biological Products, (No Diagnostic Substances)

IMTX Immatics N.V.

Market Cap
$965M
P/E Ratio
–
Size
small-cap
AI Forecast
NO CURRENT FORECAST
Full analysis →
Nasdaq · Biological Products, (No Diagnostic Substances)

VOR Vor Biopharma Inc.

Price
$19.25 +30.9% · 6M
Market Cap
$1.14B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

IMTX · VOR

Key facts

  • VOR is 1.2 times larger than IMTX by market capitalization ($1.14B against $965M).
  • Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricIMTXVOR
Market Cap$965M$1.14B
EPS$-2.52–
FCF/Share$-4.34–

Profitability & Margins

MetricIMTXVOR
ROIC-57.8%-38.6%
Tax Rate-1.2%–

Financial Health

MetricIMTXVOR
Current Ratio11.72x13.50x
Working Capital$542M–

Cash Flow

MetricIMTXVOR
Operating Cash Flow-$537M–
Free Cash Flow-$581M–
Capital Spending-$44M–
OCF Growth YoY-288.2%–

Income Statement

MetricIMTXVOR
Operating Income-$340M–
R&D Expense$467M–

Dividend & Shareholder Information

MetricIMTXVOR
Shares Outstanding134M59M
FAQ

IMTX vs VOR: stock comparison and AI forecast

Which is bigger, IMTX or VOR?

VOR is 1.2 times larger than IMTX by market capitalization ($1.14B against $965M).

Which one does Intratio's AI model rank higher, IMTX or VOR?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.